immune system
• in the spleen
|
• in the lymph node
|
• in MOG35-55-treated mice
|
• following TCR stimulation, T cells exhibit lower threshold for calcium flux compared with wild-type cells
|
• in response to antigen receptor activation
|
• in CD4+ T cells stimulated with anti-CD3 or cognate peptide, rested then restimulated with anti-CD3 or MOG35-55
• in CD8+ T cells when restimulated
|
• T cells treated with anti-CD3 or MOG35-55 are resistant to development of anergy
|
• delayed onset and reduced severity of MOG35-55-induced experimental autoimmune encephalomyelitis with fewer Th17 cells in the spinal cord
|
hematopoietic system
• in the spleen
|
• in the lymph node
|
• in MOG35-55-treated mice
|
• following TCR stimulation, T cells exhibit lower threshold for calcium flux compared with wild-type cells
|
• in response to antigen receptor activation
|
• in CD4+ T cells stimulated with anti-CD3 or cognate peptide, rested then restimulated with anti-CD3 or MOG35-55
• in CD8+ T cells when restimulated
|
cellular
• in response to antigen receptor activation
|
• in CD4+ T cells stimulated with anti-CD3 or cognate peptide, rested then restimulated with anti-CD3 or MOG35-55
• in CD8+ T cells when restimulated
|